Hearing loss and truncating variants in Alport syndrome. [PDF]
Yim HE.
europepmc +1 more source
New Insights in Fibroblast Growth Factor 23 Pathobiology in Kidney Diseases. [PDF]
Jansson KP.
europepmc +1 more source
Antiproteinuric Effect of Sparsentan in Patients with Genetic-Associated FSGS Enrolled in the DUPLEX Trial. [PDF]
Yee J +8 more
europepmc +1 more source
Genetic diagnosis of hereditary kidney disease in pediatric patients through whole-exome sequencing and mitochondrial DNA analysis. [PDF]
Oh J, Lee K, Won D, Lee YM, Shin JI.
europepmc +1 more source
Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells. [PDF]
Zheng Q +12 more
europepmc +1 more source
Update on Alport Syndrome: The Report of the 2024 International Workshop on Alport Syndrome. [PDF]
Oates TM +12 more
europepmc +1 more source
Whole transcriptome sequencing and ceRNA regulatory network in diabetic peripheral neuropathy. [PDF]
Yan Q +6 more
europepmc +1 more source
Kidney transplantation in Alport syndrome: A genotype-guided case series and literature review. [PDF]
Gavrilovska-Brzanov A +8 more
europepmc +1 more source
Alport Syndrome-Associated Pathogenic <i>COL4A4</i> Variant in Sisters With Chronic Kidney Disease: Clinical Findings and Integrative Network Analysis. [PDF]
Farooq B +4 more
europepmc +1 more source

